CVS HEALTH Corp
For the period ended Dec 31, 2024. Filed Feb 12, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 12, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CVS HEALTH CORPORATION | |||
| Date: | February 12, 2025 | By: | /s/ THOMAS F. COWHEY |
|---|---|---|---|
| Thomas F. Cowhey | |||
| Executive Vice President and Chief Financial Officer | |||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title(s) | Date |
|---|---|---|
| /s/ FERNANDO AGUIRRE | Director | February 12, 2025 |
| Fernando Aguirre | ||
| /s/ JEFFREY R. BALSER, M.D., Ph.D. | Director | February 12, 2025 |
| Jeffrey R. Balser, M.D., Ph.D. | ||
| /s/ C. DAVID BROWN II | Director | February 12, 2025 |
| C. David Brown II | ||
| /s/ JAMES D. CLARK | Senior Vice President - Controller and Chief | February 12, 2025 |
| James D. Clark | Accounting Officer (Principal Accounting Officer) | |
| /s/ THOMAS F. COWHEY | Executive Vice President and Chief Financial Officer | February 12, 2025 |
| Thomas F. Cowhey | (Principal Financial Officer) | |
| /s/ ALECIA A. DECOUDREAUX | Director | February 12, 2025 |
| Alecia A. DeCoudreaux | ||
| /s/ NANCY-ANN M. DEPARLE | Director | February 12, 2025 |
| Nancy-Ann M. DeParle | ||
| /s/ ROGER N. FARAH | Chair of the Board and Director | February 12, 2025 |
| Roger N. Farah | ||
| /s/ ANNE M. FINUCANE | Director | February 12, 2025 |
| Anne M. Finucane | ||
| /s/ J. DAVID JOYNER | President and Chief Executive Officer | February 12, 2025 |
| J. David Joyner | (Principal Executive Officer) and Director | |
| /s/ J. SCOTT KIRBY | Director | February 12, 2025 |
| J. Scott Kirby | ||
| /s/ MICHAEL F. MAHONEY | Director | February 12, 2025 |
| Michael F. Mahoney | ||
| /s/ JEAN-PIERRE MILLON | Director | February 12, 2025 |
| Jean-Pierre Millon | ||
| /s/ LESLIE V. NORWALK | Director | February 12, 2025 |
| Leslie V. Norwalk | ||
| /s/ LARRY M. ROBBINS | Director | February 12, 2025 |
| Larry M. Robbins | ||
| /s/ GUY P. SANSONE | Director | February 12, 2025 |
| Guy P. Sansone | ||
| /s/ MARY L. SCHAPIRO | Director | February 12, 2025 |
| Mary L. Schapiro | ||
| /s/ DOUGLAS H. SHULMAN | Director | February 12, 2025 |
| Douglas H. Shulman | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.